BTA
Click for more information
0.00% 57.0¢ biota holdings limited

iv relenza zanamivir gsk

  1. dma
    4,618 Posts.
    clock Created with Sketch.
    19/10/07
    19:37
    Post #: 2914953
    Well folks this is just icing on the cake, that GSK have changed their stance on Relenza....................What do you think NOW? :-)

    http://www.pslgroup.com/dg/28825a.htm

    Cheers dma
    BTA Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Achilles returns further high grade silver-goldbase metal mineralisation
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
BM8 Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.